Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Jolt Health Inc
C.JOLT
Jolt Health Inc. is a Canada-based life sciences company focused on healthcare, biotechnology and artificial intelligence. The Company holds licenses for therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America. The Company's Wellness Product Portfolio is comprised of wellness products and the underlying intellectual property, concentrating on sexual...
health, with or without the benefit of CBD, acquired pursuant to various product licenses. In particular, the Company has rights to utilize a range of products and the related intellectual property pursuant to the product licenses, including CBD oral strips (CannaStrips), Arouse RX gel with CBD and/or THC, CBD/THC biphasic mints/candies, Female Sexual Dysfunction supplement (FSD Supplement), ToConceive, and Male Enhancement Gel With CBD. The CannaStrip oral muco-adhesive strips enhance the bioavailability of hemp oil extracts and THC, increasing the impact and duration of the health benefits.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:JOLT)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
JCricket
X
Post by
JCricket
on Sep 17, 2024 4:17pm
Existing lawsuit against this company
Hello Romanus1, I started a lawsuit against Jolt Health last year, but I haven't yet found an economcially feasible way to proceed. I just want to reclaim the investment I have lost, but I
...more
(44)
•••
Romanus1
X
Post by
Romanus1
on Jul 09, 2024 1:13pm
embarrassment has to stop!!
this half cent value, and no concrete plans to bring value to this company is shameful, what management team would actually be proud of this...failure...failure...failure
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(44)
•••
Romanus1
X
Post by
Romanus1
on Jul 09, 2024 12:09pm
where is the CEO
a ceo has a duty to the company and the shareholders, when will he address this sub penny price??? If he has no plan he should resign, this is embarrassing after a pp of $500,000
(44)
•••
Romanus1
X
Post by
Romanus1
on Jul 08, 2024 2:17pm
will we ever get out of $,005??
Seems we have been at .005 for eternity.Wonder what plans the management team has made, are they trying to achieve those goals in the near term.A statement outlining those goals would be welcome news.
...more
(44)
•••
Romanus1
X
Post by
Romanus1
on Jul 07, 2024 3:43pm
no website
is it lack of funds, lack of commitment, or just ineptitude of management that a public company does not have a website?????
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Rig Count Soars as Utilization Surpasses Industry Averages
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden